TRCT
VIE

Tower Research Capital (TRC)’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Tower Research Capital (TRC)’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,594
Closed -$129K – 6018
2020
Q4 		$129K Buy
3,594
+2,040
+131% +$71.5K ﹤0.01% 2114
2020
Q3 		$44K Sell
1,554
-2,641
-63% -$93.4K ﹤0.01% 3592
2020
Q2 		$182K Buy
+4,195
New +$190K 0.01% 1877

Tower Research Capital (TRC)'s VIE Position: Q1 2021 in Review

Tower Research Capital (TRC) sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 3,594 shares — an estimated $129K sold.

Tower Research Capital (TRC) first reported a position in VIE in Q2 2020 and held it in 3 quarters. The position peaked at $182K in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • Tower Research Capital (TRC) reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,594 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $129K.
  • Tower Research Capital (TRC) first reported a position in Viela Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s Viela Bio, Inc. Common Stock position peaked at $182K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.